133 related articles for article (PubMed ID: 20478811)
1. [Elevated serum dipeptidyl peptidase-4 activity in type 1 diabetes mellitus: a direct comparison].
Varga T; Firneisz G; Nagy G; Somogyi A
Orv Hetil; 2010 May; 151(22):899-902. PubMed ID: 20478811
[TBL] [Abstract][Full Text] [Related]
2. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.
Ryskjaer J; Deacon CF; Carr RD; Krarup T; Madsbad S; Holst J; Vilsbøll T
Eur J Endocrinol; 2006 Sep; 155(3):485-93. PubMed ID: 16914604
[TBL] [Abstract][Full Text] [Related]
3. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes.
Varga T; Somogyi A; Barna G; Wichmann B; Nagy G; Rácz K; Selmeci L; Firneisz G
Pathol Oncol Res; 2011 Dec; 17(4):925-30. PubMed ID: 21785903
[TBL] [Abstract][Full Text] [Related]
4. Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.
McKillop AM; Duffy NA; Lindsay JR; O'Harte FP; Bell PM; Flatt PR
Diabetes Res Clin Pract; 2008 Jan; 79(1):79-85. PubMed ID: 17904681
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus.
Mannucci E; Pala L; Ciani S; Bardini G; Pezzatini A; Sposato I; Cremasco F; Ognibene A; Rotella CM
Diabetologia; 2005 Jun; 48(6):1168-72. PubMed ID: 15864535
[TBL] [Abstract][Full Text] [Related]
6. Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects.
Ahmed RH; Huri HZ; Al-Hamodi Z; Salem SD; Muniandy S
PLoS One; 2015; 10(10):e0140618. PubMed ID: 26474470
[TBL] [Abstract][Full Text] [Related]
7. Persons with latent autoimmune diabetes in adults express higher dipeptidyl peptidase-4 activity compared to persons with type 2 and type 1 diabetes.
Duvnjak L; Blaslov K; Vučić Lovrenčić M; Knežević Ćuća J
Diabetes Res Clin Pract; 2016 Nov; 121():119-126. PubMed ID: 27693949
[TBL] [Abstract][Full Text] [Related]
8. Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.
Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Yokoyama H; Haneda M
Front Endocrinol (Lausanne); 2020; 11():214. PubMed ID: 32390941
[No Abstract] [Full Text] [Related]
9. The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients.
Fadini GP; Albiero M; Menegazzo L; de Kreutzenberg SV; Avogaro A
Diabetes Obes Metab; 2012 Jun; 14(6):518-22. PubMed ID: 22171692
[TBL] [Abstract][Full Text] [Related]
10. Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?
Andersen ES; Lund A; Bagger JI; Andreasen C; Grøndahl MF; Deacon CF; Hartmann B; Holst JJ; Knop FK; Vilsbøll T
Diabetes Obes Metab; 2018 Aug; 20(8):1937-1943. PubMed ID: 29654643
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of dipeptidyl peptidase-IV (DPP-IV) in Indian type-2 diabetic population.
Venkatesham A; Srinivas M; Krishna DR; Narayana P
J Assoc Physicians India; 2009 Sep; 57():627-30. PubMed ID: 20213998
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase-4 activity is associated with urine albumin excretion in type 1 diabetes.
Duvnjak L; Perković MN; Blaslov K
J Diabetes Complications; 2017 Jan; 31(1):218-222. PubMed ID: 27625045
[TBL] [Abstract][Full Text] [Related]
14. Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.
Firneisz G; Varga T; Lengyel G; Fehér J; Ghyczy D; Wichmann B; Selmeci L; Tulassay Z; Rácz K; Somogyi A
PLoS One; 2010 Aug; 5(8):e12226. PubMed ID: 20805868
[TBL] [Abstract][Full Text] [Related]
15. Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes.
Aso Y; Kase M; Sagara M; Sakurai S; Iijima T; Tomaru T; Jojima T; Usui I
Am J Med Sci; 2020 Sep; 360(3):261-267. PubMed ID: 32540146
[TBL] [Abstract][Full Text] [Related]
16. Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.
Østoft SH; Bagger JI; Hansen T; Hartmann B; Pedersen O; Holst JJ; Knop FK; Vilsbøll T
Eur J Endocrinol; 2015 Aug; 173(2):205-15. PubMed ID: 25953829
[TBL] [Abstract][Full Text] [Related]
17. DPP-4 inhibitor treatment: β-cell response but not HbA
Kozlovski P; Bhosekar V; Foley JE
Vasc Health Risk Manag; 2017; 13():123-126. PubMed ID: 28408838
[TBL] [Abstract][Full Text] [Related]
18. Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes.
Ghosh I; Mukhopadhyay P; Das K; Anne M B; Ali Mondal S; Basu M; Nargis T; Pandit K; Chakrabarti P; Ghosh S
J Diabetes; 2021 Jun; 13(6):506-511. PubMed ID: 33247879
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antidiabetic effects of dipeptidyl peptidase-IV inhibitor ASP8497 in streptozotocin-nicotinamide-induced mildly diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Pharmacology; 2009; 83(3):177-87. PubMed ID: 19176982
[TBL] [Abstract][Full Text] [Related]
20. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
